Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
A Randomized, Double-blind, Placebo-controlled and Multicenter Phase Ⅱ Clinical Trials To
Evaluate the Safety, Efficacy and Pharmacokinetics of GST-HG141 Tablets in Treated Chronic
Hepatitis B (CHB) Patients With Low Viremia.